G. Gurevičienė, “PD-L1 INHIBITOR ATEZOLIZUMAB▼ - FOR NSCLC TREATMENT AFTER PRIOR CHEMOTHERAPY”, PIA, vol. 3, no. 1, pp. 102-108, Sep. 2020.